Naresh Reddivalla, MD | |
1432 S Dobson Rd Ste 107, Mesa, AZ 85202-4769 | |
(480) 412-4100 | |
Not Available |
Full Name | Naresh Reddivalla |
---|---|
Gender | Male |
Speciality | Pediatrics - Pediatric Hematology-oncology |
Location | 1432 S Dobson Rd Ste 107, Mesa, Arizona |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073851150 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0207X | Pediatrics - Pediatric Hematology-oncology | 53522 (Arizona) | Primary |
Entity Name | Banner -- University Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508809427 PECOS PAC ID: 7719899871 Enrollment ID: O20031105000694 |
News Archive
For the first time, investigators in the Division of Infectious Diseases at the University of North Carolina School of Medicine have determined how antiretroviral therapy (ART) affects the way HIV disseminates and establishes infection in the female reproductive tract.
Research examining adults with moderate to severe traumatic brain injury (TBI) who participated in rehabilitation showed that they were twice as likely to die from an unintentional injury that occurred following their TBI.
A research team from the University of Copenhagen and University of Helsinki demonstrates it is possible to predict individual preferences based on how a person's brain responses match up to others. This could potentially be used to provide individually-tailored media content - and perhaps even to enlighten us about ourselves.
The U.S. Food and Drug Administration (FDA) has notified Mallinckrodt, the pharmaceuticals business of Covidien, that it has approved a 32 mg tablet strength of EXALGO (hydromorphone HCI) Extended-Release Tablets (CII) for opioid-tolerant patients with moderate-to-severe chronic pain requiring continuous around-the-clock opioid analgesia for an extended period of time.
› Verified 9 days ago
Entity Name | Banner Cancer Center Specialists Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518253152 PECOS PAC ID: 6103097779 Enrollment ID: O20110913000224 |
News Archive
For the first time, investigators in the Division of Infectious Diseases at the University of North Carolina School of Medicine have determined how antiretroviral therapy (ART) affects the way HIV disseminates and establishes infection in the female reproductive tract.
Research examining adults with moderate to severe traumatic brain injury (TBI) who participated in rehabilitation showed that they were twice as likely to die from an unintentional injury that occurred following their TBI.
A research team from the University of Copenhagen and University of Helsinki demonstrates it is possible to predict individual preferences based on how a person's brain responses match up to others. This could potentially be used to provide individually-tailored media content - and perhaps even to enlighten us about ourselves.
The U.S. Food and Drug Administration (FDA) has notified Mallinckrodt, the pharmaceuticals business of Covidien, that it has approved a 32 mg tablet strength of EXALGO (hydromorphone HCI) Extended-Release Tablets (CII) for opioid-tolerant patients with moderate-to-severe chronic pain requiring continuous around-the-clock opioid analgesia for an extended period of time.
› Verified 9 days ago
Entity Name | Banner Physician Super Specialists Arizona Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1841573870 PECOS PAC ID: 7911173794 Enrollment ID: O20111228000353 |
News Archive
For the first time, investigators in the Division of Infectious Diseases at the University of North Carolina School of Medicine have determined how antiretroviral therapy (ART) affects the way HIV disseminates and establishes infection in the female reproductive tract.
Research examining adults with moderate to severe traumatic brain injury (TBI) who participated in rehabilitation showed that they were twice as likely to die from an unintentional injury that occurred following their TBI.
A research team from the University of Copenhagen and University of Helsinki demonstrates it is possible to predict individual preferences based on how a person's brain responses match up to others. This could potentially be used to provide individually-tailored media content - and perhaps even to enlighten us about ourselves.
The U.S. Food and Drug Administration (FDA) has notified Mallinckrodt, the pharmaceuticals business of Covidien, that it has approved a 32 mg tablet strength of EXALGO (hydromorphone HCI) Extended-Release Tablets (CII) for opioid-tolerant patients with moderate-to-severe chronic pain requiring continuous around-the-clock opioid analgesia for an extended period of time.
› Verified 9 days ago
Entity Name | Banner - University Super Specialists Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740650555 PECOS PAC ID: 1850695255 Enrollment ID: O20160204002443 |
News Archive
For the first time, investigators in the Division of Infectious Diseases at the University of North Carolina School of Medicine have determined how antiretroviral therapy (ART) affects the way HIV disseminates and establishes infection in the female reproductive tract.
Research examining adults with moderate to severe traumatic brain injury (TBI) who participated in rehabilitation showed that they were twice as likely to die from an unintentional injury that occurred following their TBI.
A research team from the University of Copenhagen and University of Helsinki demonstrates it is possible to predict individual preferences based on how a person's brain responses match up to others. This could potentially be used to provide individually-tailored media content - and perhaps even to enlighten us about ourselves.
The U.S. Food and Drug Administration (FDA) has notified Mallinckrodt, the pharmaceuticals business of Covidien, that it has approved a 32 mg tablet strength of EXALGO (hydromorphone HCI) Extended-Release Tablets (CII) for opioid-tolerant patients with moderate-to-severe chronic pain requiring continuous around-the-clock opioid analgesia for an extended period of time.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Naresh Reddivalla, MD 1432 S Dobson Rd, Mesa, AZ 85202-4768 Ph: (480) 412-4100 | Naresh Reddivalla, MD 1432 S Dobson Rd Ste 107, Mesa, AZ 85202-4769 Ph: (480) 412-4100 |
News Archive
For the first time, investigators in the Division of Infectious Diseases at the University of North Carolina School of Medicine have determined how antiretroviral therapy (ART) affects the way HIV disseminates and establishes infection in the female reproductive tract.
Research examining adults with moderate to severe traumatic brain injury (TBI) who participated in rehabilitation showed that they were twice as likely to die from an unintentional injury that occurred following their TBI.
A research team from the University of Copenhagen and University of Helsinki demonstrates it is possible to predict individual preferences based on how a person's brain responses match up to others. This could potentially be used to provide individually-tailored media content - and perhaps even to enlighten us about ourselves.
The U.S. Food and Drug Administration (FDA) has notified Mallinckrodt, the pharmaceuticals business of Covidien, that it has approved a 32 mg tablet strength of EXALGO (hydromorphone HCI) Extended-Release Tablets (CII) for opioid-tolerant patients with moderate-to-severe chronic pain requiring continuous around-the-clock opioid analgesia for an extended period of time.
› Verified 9 days ago
Jyoti S. Lebonheur, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1840 S. Stapley Drive, Suite 101, Mesa, AZ 85204 Phone: 480-464-8500 | |
Dr. Eric Gabriel Gonzalez, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 616 E Southern Ave, #103, Mesa, AZ 85204 Phone: 602-569-3999 Fax: 602-569-3887 | |
Pacita Tee Opulencia, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 59 S Hibbert, Mesa, AZ 85210 Phone: 480-344-6226 Fax: 602-344-6201 | |
Dr. Daniel E Miga, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1432 S Dobson Rd Ste 512, Mesa, AZ 85202 Phone: 480-412-6336 Fax: 480-412-8013 | |
Dale W Guthrie, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4540 E Baseline Rd, Suite 108, Mesa, AZ 85206 Phone: 480-892-3880 Fax: 480-545-4551 | |
Dr. Leno Mammen Thomas, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1432 S Dobson Rd Ste 506, Mesa, AZ 85202 Phone: 480-412-6430 |